Direxion Daily S&P Biotech Bull 3x Shares (LABU) News Today $106.77 +0.77 (+0.73%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHoldingsOwnershipRatings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ULTY: ~74% Trailing Yield, But Look Out BelowOctober 11, 2024 | seekingalpha.comDirexion Daily S&P 500 Bull 3X Shares declares quarterly distribution of $0.3367September 24, 2024 | msn.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1502September 24, 2024 | msn.comDirexion Daily FTSE Europe Bull 3X Shares (EURL)May 17, 2024 | investing.comThe 3 Best Leveraged ETFs for April 2024April 2, 2024 | investorplace.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1606March 21, 2024 | msn.comLABU: A Really Bad DriftMarch 4, 2024 | seekingalpha.comDirexion Daily S&P Biotech Bull 3X Shares (LABU)January 22, 2024 | finance.yahoo.comLABU: Buy As The Biotech Sector Starts A New Bull Market (Technical Analysis)December 16, 2023 | seekingalpha.comLABU: Tool For Swing TradersDecember 10, 2023 | seekingalpha.comUVXY, LABU and NAIL among weekly ETF moversNovember 4, 2023 | msn.comDirexion Announces Reverse Splits of TMF and LABUNovember 3, 2023 | finance.yahoo.comLABU And LABD: Another Attractive Double-Short Pairs TradeSeptember 29, 2023 | msn.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.0020September 20, 2023 | msn.comLABU: A Levered ETF Doomed From The StartAugust 20, 2023 | msn.comUnusual Call Option Trade in Direxion Daily S&P Biotech Bull 3X Shares (LABU) Worth $124.42KMay 12, 2023 | msn.comUnusual Call Option Trade in Direxion Daily S&P Biotech Bull 3X Shares (LABU) Worth $162.00KApril 25, 2023 | msn.comDirexion Daily Software Bull 2X Shares declares quarterly distribution of $0.0070March 24, 2023 | msn.comWant Diversified Upside in Biotechnology? Check out LABUWatch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.March 22, 2023 | marketbeat.comLABU: Leveraged Biotech ETF ReviewJanuary 31, 2023 | seekingalpha.comHow to Trade the High-Growth Biotech Sector in the Midst of a Bear MarketNovember 23, 2022 | benzinga.comLABU: Opportunities For Gains Exist If Bought And Sold At Correct PriceOctober 29, 2022 | seekingalpha.comDirexion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU.MX)August 9, 2022 | ca.finance.yahoo.comDirexion Daily S&P Biotech Bull 3X Shares NewsJuly 2, 2022 | thestreet.comTaking On Volatility With Geared ETFsFebruary 8, 2022 | finance.yahoo.comWhy Moderna Stock Needs To Hold This Support LevelNovember 4, 2021 | benzinga.com Get Direxion Daily S&P Biotech Bull 3x Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for LABU and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. LABU Media Mentions By Week LABU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LABU News Sentiment▼0.000.58▲Average News Sentiment LABU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LABU Articles This Week▼00▲LABU Articles Average Week Get Direxion Daily S&P Biotech Bull 3x Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for LABU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VanEck Pharmaceutical ETF News Today iShares U.S. Pharmaceuticals ETF News Today Invesco S&P SmallCap Health Care ETF News Today Simplify Health Care ETF News Today SPDR S&P Pharmaceuticals ETF News Today ALPS Medical Breakthroughs ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Invesco Nasdaq Biotechnology ETF News Today ProShares UltraShort Nasdaq Biotechnology News Today Langar Global HealthTech ETF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:LABU) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
